CY21 will be marked with hopes of early roll-out of the Covid-19 vaccine, normalisation of activities and unperturbed growth recovery. We expect CY21/FY22 to be a better year with likely strong recovery in both the economy and earnings. There will be a remarkable shift in Nominal GDP growth from (-) 6.1% in FY21E to 14% in FY22E which will help corporates to report healthy revenue and earnings growth. This year’s high base effect will keep inflation on a gradual glide path towards 4.8% in FY22. We expect average inflation in FY22E to be 4.7% Vs 6.4% in FY21E. Fiscal consolidation is unlikely to be sharp with gross borrowing only marginally lower than FY21E. However, due to the sharp rise in Nominal GDP growth expect centre’s Gross Fiscal Deficit/GDP to come down to 5.5% in FY22E Vs 7.1% in FY21E. We expect the 10-year GSec yield to inch higher towards 6.25%-6.5% in 2HFY22.
We expect earnings of the Nifty-50 Index to rise by 11% in FY21E, by 28% in FY22E and 19% in FY23E. We see a sharp recovery in FY22E net profit coming from automobiles, banks, metals and telecom sector. Our updated free float EPS for Nifty-50 stands at Rs.488 for FY21E, Rs.628 for FY22E and Rs.746 for FY23E. It is interesting to note that last five years earnings CAGR of Nifty-50 has been just 2.6% (i.e. FY16-20). On the low base we expect Nifty-50 earnings CAGR for the period of FY20-23E to be ~18%.
With fresh stimulus coming from BoJ & ECB and likely stimulus coming from Fed early next year we expect FPI flows to remain strong in initial months of CY21. Overall we expect FII flows to range between US$ 15 & 20 bn in CY21 as compared to more than US$ 23 bn received in this calendar year. CY20 has favoured the high growth and beta stocks. Most of the high growth and quality stocks are now ‘priced to perfection’ leaving scope for potential re-rating in value stocks. As we go into CY21 with few vaccines coming in the market it is be ideal to play the recovery theme for next year. In this scenario cyclical sectors and stocks could score over defensives in CY21. Returns, in CY21 could be more broad-based as compared to the wide divergence seen in CY21. Returns could also be a function of earnings upgrades and potential of any re-rating which could be higher in case of value stocks in CY21.
We see markets behaving differently in first half and second half of CY21. Q3 earnings season could turn to be strong due to healthy advance tax figures and also lead to some earnings upgrades. We can expect Nifty to go anywhere between 14,000 & 15,000 range sometime in first quarter of CY21. Post budget and Q4 result season we expect markets to go into some kind of consolidation phase and witness time correction. We expect moderation in monetary policies and rising yields scenario in 2HCY21, which will lead to mean reversion of valuations towards 10/15 year averages. Based on these thesis we have used the previous 15 years peak of 19x Fw PE multiple to value the Nifty-50 to derive at our CY21 end target. We expect Nifty-50 to end CY21 somewhere ~13,500 and BSE Sensex to end at ~46,000.